J. Goldman & Co LP - ADAMAS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$422,000
-65.1%
97,480
+36.3%
0.02%
-73.8%
Q4 2016$1,208,000
-38.6%
71,500
-40.4%
0.08%
-27.9%
Q3 2016$1,967,000
-23.1%
119,867
-29.1%
0.11%
-17.2%
Q2 2016$2,559,000–169,000–0.13%–
 Download
Other shareholders

There were no reported owners of ADAMAS PHARMACEUTICALS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of ADAMAS PHARMACEUTICALS INC shareholders